Merck has announced it will be cutting 1,100 jobs in Germany by the end of 2015, as part of the company’s “Fit for 2018” business transformation program spanning all Merck’s businesses and ...

U.S. equities finished higher during the third quarter, with 10 of 11 GICS sectors posting positive returns. Click here to ...

Merck (NYSE: MRK) stock has been a longtime winner ... Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $729,857!* ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

The price of ethereum, or 1 ETH, traded at $2,581.58, as of 8 a.m. ET. The highest intraday price that ethereum reached in ...

Facing a shortage of planes due to Western sanctions, Russia is in talks with some Central Asian countries for their airlines ...

Summit Therapeutics (NASDAQ: SMMT) has soared 1,000% over the past year on progress in developing a drug that could rival Merck's Keytruda, a product used to treat various cancers with over $25 ...

Enrollment on track in registrational Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 75 ...

During the monitoring period, after the seasonal influenza period had ended, 59 wastewater treatment plants showed increases ...

Rutgers will receive $50 million from the National Institutes of Health, the backbone of funding for research work planned at ...

The price of ethereum, or 1 ETH, traded at $2,649.24, as of 8 a.m. ET. The highest intraday price that ethereum reached in ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...